Nutex Health is a high-quality business with an excellent earnings track record, but the risk/reward has compressed near its 52-week high, leaving thin modeled upside despite a supportive short-squeeze setup.
Thesis pillars
- High Quality Roe Cash Conversion↓Deteriorating
- Thin Upside Asymmetry Failure↓Deteriorating
- Earnings Beat Streak Catalyst→Stable
- +2 more pillars — see the Why tab for full reasoning
Nutex Health Inc. (NUTX) Stock Analysis
Breakout setup · Inst Constrain edge
Healthcare · Medical Care Facilities
Wait for pullback to $177.47. BUY gates pass at $185.48, but concentration risk — Counterparty: HaloMD (exclusive IDR claims processor) and weak growth argue for a more patient entry. Engine's entry $177.47 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum.
Nutex Health is a physician-led healthcare services company operating 26 micro-hospital and specialty hospital facilities across 12 states as of December 31, 2025, alongside a population health management division that manages four independent physician associations (IPAs) with... Read more
Wait for pullback to $177.47. BUY gates pass at $185.48, but concentration risk — Counterparty: HaloMD (exclusive IDR claims processor) and weak growth argue for a more patient entry. Engine's entry $177.47 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.1/10, moderate confidence.
Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news boost analyst 0.70, earnings proximity 83d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
About Nutex Health Inc.
About Nutex Health Inc.
Nutex Health generated $875.3 million in total revenue during 2025, more than 82 percent higher than the $479.9 million reported in 2024, with $844.2 million coming from its hospital division and $31.1 million from population health management. The company operated 26 micro-hospital and specialty hospital facilities across 12 states as of December 31, 2025, employing 944 full-time staff, contracting more than 280 doctors, and partnering with over 3,600 physicians and specialists across its independent physician association (IPA) networks.
Nutex Health's hospital division operates as an out-of-network provider that generally lacks negotiated reimbursement rates with insurers, collecting more than 99 percent of net patient service revenue from insurers, federal agencies and other third-party payors rather than direct patient payments. New hospital locations are typically structured across three separately owned entities, a real estate entity, a physician LLC, and a hospital facility in which Nutex holds 60 percent or greater equity, with in-market physicians co-investing in each; many of these entities are controlled by Chairman and CEO Dr. Vo. The population health management division, through its Management Services Organization, manages independent physician associations in Los Angeles, Houston, South Florida and Phoenix, with the Los Angeles IPA alone counting over 230 primary care physicians, 2,800 specialists and roughly 32,750 enrolled patients.
Show full overview
Nutex Health's out-of-network reimbursement depends on a single vendor: HaloMD has handled, on an exclusive basis, all of the company's claims eligible for arbitration under the federal No Surprises Act since May 2024, submitting an estimated 50 to 60 percent of Nutex's medical claims through the Independent Dispute Resolution process in 2025, and Nutex has no contractual right to audit HaloMD's underlying methodology or filings. That dependency drew scrutiny after a July 22, 2025 short-seller report, built partly on insurer lawsuits accusing HaloMD of submitting arbitration-ineligible claims, sent Nutex shares down 16.4 percent in a single session, followed by a second critical report on November 25, 2025.
See also: Healthcare · Medical Care Facilities
From Nutex Health Inc.'s most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-08-14Recent Developments — Nutex Health Inc.
Latest news
- NEWS NUTX|Nutex Health Inc|Price:148.790|Chg%:+0.090 - TradingKey — TradingKey neutral
- NEWS Nutex Health Inc (NUTX) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS Nutex Health Inc. (NUTX) Q1 2026 Earnings: EPS Surges Past Estimates Amid Limited Revenue Disclosure - Earnings Miss Str — dars.gov.et negative
- NEWS Nutex Health Inc (NUTX) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 75/100 - GuruFocus — GuruFocus positive
- NEWS Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade) (NUTX) - Seeking Alpha — Seeking Alpha positive
Generated 2026-08-14T14:47:41Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHcounterpartyHaloMD (exclusive IDR claims processor)10-K Item 1A: 'Since May 2024, HaloMD has handled, on an exclusive basis, all out-of-network claims made by Nutex that are eligible for arbitration under federal and state “no surprise” laws.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Revenue shrinking — -13.6% YoY. Growth thesis broken unless recovery story develops.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $177.47. BUY gates pass at $185.48, but concentration risk — Counterparty: HaloMD (exclusive IDR claims processor) and weak growth argue for a more patient entry. Engine's entry $177.47 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $231.77 (+25.0%), stop $149.80 (−23.8%), A.R:R 1.7:1. Score 6.1/10, moderate confidence.
Take-profit target: $231.77 (+25.0% upside). Target $231.77 (+25.0%), stop $149.80 (−23.8%), A.R:R 1.7:1. Stop-loss: $149.80.
Concentration risk — Counterparty: HaloMD (exclusive IDR claims processor); Weak growth.
Nutex Health Inc. trades at a P/E of 6.7 (forward 9.2). TrendMatrix value score: 8.9/10. Verdict: Buy (Wait for Entry).
11 analysts cover NUTX with a consensus score of 4.1/5. Average price target: $266.
What does Nutex Health Inc. do?Nutex Health is a physician-led healthcare services company operating 26 micro-hospital and specialty hospital...
Nutex Health is a physician-led healthcare services company operating 26 micro-hospital and specialty hospital facilities across 12 states as of December 31, 2025, alongside a population health management division that manages four independent physician associations (IPAs) with about 38,000 enrolled members. The company generated $875.3 million in total revenue in 2025, up from $479.9 million in 2024, with $844.2 million from the hospital division; more than 99% of hospital net patient service revenue is paid by insurers, federal agencies and other third parties rather than patients directly.